- 
BABA is testing 200 SMA
-BABA moves are explodes higher then cools then retest support then explodes higher than the last high. It's called trading with higher wavelength
-> Move 1: Started April 2024 when the trend reversal started. $68 -> $89 with around +30% then retraced $90 -> $72 ( -20% )
-> Move 2: July 2024, $72 -> $116 (+61%) then retraced $116 -> $80 ( -31% )
-> Move 3: Jan 2025, $80 -> $146 (+ 82.5%) then retraced $146 -> $108?? ( correction underway ) ~ -26% so far
-> Move 4: Likely from $100-105 to $180-200
BABA is testing 200 SMA -
BABA moves are explodes higher then cools then retest support then explodes higher than the last high. It's called trading with higher wavelength-> Move 1: Started April 2024 when the trend reversal started. $68 -> $89 with around +30% then retraced $90 -> $72 ( -20% )
-> Move 2: July 2024, $72 -> $116 (+61%) then retraced $116 -> $80 ( -31% )
-> Move 3: Jan 2025, $80 -> $146 (+ 82.5%) then retraced $146 -> $108?? ( correction underway ) ~ -26% so far
-> Move 4: Likely from $100-105 to $180-200
Nota
NVDA can export chips to China. NVDA revenue would increase but the biggest benefits would be for BABA as it has good AI talent and soon they would have access to NVDA GPUs which will close gaps for LLM capabilities coming out of BABA research and they would be able to close the GAP with Anthropic, Meta LLAMA and Google Gemini and might even compete with Open AINota
Trade deal with China is bullish for BABATrade chiuso manualmente
Closing this post in lieu of my other post. I want to keep updates at one place:
Nota
- BABA is having a bullish breakout on July 27, 2025. What a good day to have this bullish breakout when Macro is also aligning for Chinese Equities as US extends its tariff on China. Reference:
cnbc.com/2025/07/27/us-china-trade-tariff-talks.html
Nota
Price Target for BABA is $175-200
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.